EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dermal Nerve Sheath Myxomas Harbor Recurrent DPYSL2::CDX1 Fusions and Expand the Spectrum of CDX1-Rearranged Soft Tissue Tumors

Carina A Dehner, Laura M Warmke, Sion W Jasmine, Jessica Mercer, Michal Michal, Jiří Soukup, Tomáš Vaněček, Petr Šteiner, Petr Grossmann, Michael Michal

Modern Pathology · 2026-10 · 101101

DOI: 10.1016/j.modpat.2026.101101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2026-10. Verfasst von Carina A Dehner und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Hospital of the University of Pennsyl…. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dermal nerve sheath myxoma (DNSM) is a rare benign mesenchymal tumor with presumed nerve sheath differentiation with distinctive morphologic and immunophenotypic features; however, its molecular pathogenesis remains poorly understood. We investigated a series of nine morphologically classic DNSMs and performed molecular testing to identify recurrent genetic alterations. The cohort included five female and four male patients (median age: 56 years; range: 23-75 years). Tumors arose predominantly on the extremities and presented as multinodular dermal-based myxoid neoplasms composed of uniform spindled to epithelioid cells arranged in reticular cords within abundant myxoid stroma. Vacuolated "signet ring-like" cells were identified in all tumors. Immunohistochemically, all tested tumors showed diffuse S100, SOX10 and GFAP expression, and a subset focally expressed EMA, keratin AE1/AE3, and GLUT1. RNA-based sequencing identified an identical in-frame DPYSL2::CDX1 fusion in 7 of 9 cases. Fluorescence in situ hybridization testing using CDX1 and DPYSL2 break apart probes as well as DPYSL2/CDX1 dual-fusion probe confirmed rearrangement in 6/7 tested tumors. We herein demonstrate that most DNSM are characterized by recurrent DPYSL2::CDX1 fusions, representing the first recurrent molecular alteration identified in this tumor type. These findings further support the classification of DNSM as a distinct neoplastic entity and highlight the potential utility of molecular testing as a diagnostic adjunct in morphologically challenging cases. Further studies are warranted to clarify the biologic role of CDX1-related fusions and their relationship to other fusion-driven soft tissue neoplasms, particularly those with CDX1/CDX2 fusions.

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: carina.dehner@p…
  • Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana.
  • Georgia Dermatology Partners, Brookhaven, Georgia.
  • Biopticka Laboratory, Ltd, Plzen, Czech Republic; Department of Pathology, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic; Cytopathos, Ltd, Bratislava, Slovakia. Electronic address: carina.deh…
  • Department of Pathology, Military University Hospital, Prague, Czech Republic; Department of Pathology, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic; Th…
  • Biopticka Laboratory, Ltd, Plzen, Czech Republic; Department of Pathology, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic.

Zitieren

APA

Dehner, C. A., Warmke, L. M., Jasmine, S. W., Mercer, J., Michal, M., Soukup, J., Vaněček, T., Šteiner, P., Grossmann, P., & Michal, M. (2026). Dermal Nerve Sheath Myxomas Harbor Recurrent DPYSL2::CDX1 Fusions and Expand the Spectrum of CDX1-Rearranged Soft Tissue Tumors. Modern Pathology, 101101. https://doi.org/10.1016/j.modpat.2026.101101

Vancouver

Dehner CA, Warmke LM, Jasmine SW, Mercer J, Michal M, Soukup J, et al. Dermal Nerve Sheath Myxomas Harbor Recurrent DPYSL2::CDX1 Fusions and Expand the Spectrum of CDX1-Rearranged Soft Tissue Tumors. Modern Pathology. 2026:101101. doi:10.1016/j.modpat.2026.101101

BibTeX
@article{Dehner2026,
  author = {Dehner, Carina A and Warmke, Laura M and Jasmine, Sion W and Mercer, Jessica and Michal, Michal and Soukup, Jiří and Vaněček, Tomáš and Šteiner, Petr and Grossmann, Petr and Michal, Michael},
  title = {Dermal Nerve Sheath Myxomas Harbor Recurrent DPYSL2::CDX1 Fusions and Expand the Spectrum of CDX1-Rearranged Soft Tissue Tumors},
  journal = {Modern Pathology},
  year = {2026},
  pages = {101101},
  doi = {10.1016/j.modpat.2026.101101}
}
Kostenlos starten →